JNJ - J&J Bristol Myers slip as FDA comments on CAR-T drugs ahead of AdCom
2024-03-13 09:23:45 ET
More on Bristol-Myers, Johnson & Johnson, etc.
- Johnson & Johnson (JNJ) Leerink Partners Global Biopharma Conference (Transcript)
- Bristol-Myers Squibb: Finally Trending Up
- Bristol-Myers Squibb: Turnaround Expected
- J&J submits sBLA for Tremfya for ulcerative colitis
- Societe Generale cuts Bristol Myers to hold, cites patent expiries